About: COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention
Creator	Ouimet, Mireille Pignatelli, Pasquale Baquedano, Mai Caputo, Massimo Iacobazzi, Dominga Madeddu, Paolo Shimabukuro, Michio
source	Medline; PMC
abstract	While the COVID-19 pandemic continues to spread rapidly, resulting in considerable morbidity and mortality worldwide, multiple efforts are being made by the international scientific community to understand the pathogenesis of the viral infection and its clinical outcome. Older age and comorbidities have consistently been reported as risk factors for unfavorable prognosis, with cardiovascular disease accounting for up to 10 % of comorbid conditions among the infected patients. An understanding of the mechanism underlying the effect of this infection on patients with cardiovascular disease is essential to manage and improve clinical strategies against the disease in that population. In this review, we summarize the impact of COVID-19 on patients with underlying cardiovascular conditions and the cardiac implications of known and emerging therapeutic strategies. Our future effort will aim to further elucidate how the type and severity of the cardiac disease, with particular regard to Congenital Heart Disease, influences the prognosis and the outcome of the viral infection.
has issue date	2020-07-14(xsd:dateTime)
bibo:doi	10.3389/fcvm.2020.00140
bibo:pmid	32760740
has license	cc-by
sha1sum (hex)	760cbf4a9792e537e95b71617e5db67e90618c56
schema:url	https://doi.org/10.3389/fcvm.2020.00140
resource representing a document's title	COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention
has PubMed Central identifier	PMC7371783
has PubMed identifier	32760740
schema:publication	Front Cardiovasc Med
resource representing a document's body	covid:760cbf4a9792e537e95b71617e5db67e90618c56#body_text
is schema:about of	named entity 'viral infection' named entity 'strategies' named entity 'emerging' named entity 'Potential' named entity 'INTERNATIONAL' named entity 'COMMUNITY' named entity 'COVID-19 PANDEMIC' named entity 'PATIENTS' named entity 'infected' named entity 'Heart Disease' named entity 'scientific community' named entity 'Myocardial' named entity 'Older age' named entity 'therapeutic strategies' named entity 'pathogenesis' named entity 'COVID-19 pandemic' named entity 'morbidity' named entity 'prognosis' named entity 'COVID-19' named entity 'Pediatric' named entity 'COVID' named entity 'MSCs' named entity 'myofibroblasts' named entity 'post-mortem' named entity 'critically ill patients' named entity 'cytokine storm' named entity 'virus' named entity 'ARDS' named entity 'Italian' named entity 'vascular bed' named entity 'fluid resuscitation' named entity 'SARS' named entity 'coronary artery' named entity 'pulmonary fibrosis' named entity 'clinical trials' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity '1, 2' named entity 'pandemics' named entity 'etiology' named entity 'inotropic' named entity 'adverse effect' named entity 'pulmonary circulation' named entity 'pathological conditions' named entity 'COVID' named entity 'COVID-19' named entity 'immunomodulatory' named entity 'IgA' named entity 'congenital' named entity 'enzyme inhibitors' named entity 'Middle East Respiratory Syndrome' named entity 'inflammatory response' named entity 'lymphocytopenia' named entity 'troponin' named entity 'cardiovascular' named entity 'inflammatory conditions' named entity 'IL-6' named entity 'cardiac involvement' named entity 'oxygen saturation' named entity 'cytokines' named entity 'COVID-19' named entity 'lymphadenopathy' named entity 'cell-based therapy' named entity 'intravenous immunoglobulin' named entity 'trophic factors' named entity 'pediatric' named entity 'COVID-19' named entity 'respiratory symptoms' named entity 'myocardial infarction' named entity 'cytokine storm' named entity 'pediatric' named entity 'systemic lupus erythematosus' named entity 'angiotensin receptor blockers' named entity 'cardiovascular disorders' named entity 'inflammatory markers'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software